Press release
Cyclosporine Drugs Market Share, Trends, Growth, Future Prospects, Forecast 2020 to 2026
Cyclosporine Drugs Market
Request a Free Sample of our Report on Cyclosporine Drugs Market: https://www.omrglobal.com/request-sample/cyclosporine-drugs-market
AbbVie Inc., Allergan PLC, Apotex Inc., Eon Labs, Mayne Pharma Group Ltd. McKesson Medical-Surgical Inc., Novartis Inc., Santen Inc., Sun Pharmaceuticals, Teva Pharmaceuticals, and so on are the key players operating in the global cyclosporine drugs market. These players are actively involved in adopting different growth strategies such as mergers and acquisitions, partnerships, collaboration, and strategic agreements among others to remain competitive in the market place. New product launches and investment in the R&D is the key strategy adopted by the players of the global cyclosporine drugs market to sustain their marketplace.
For instance, in March 2019, Breath Therapeutics Inc. had announced the launch of a Ph3 trial for the inhaled liposomal cyclosporine A therapy. In August 2018, Sun Pharmaceutical Industries Ltd. had received US FDA approval for CEQUA (cyclosporine ophthalmic solution) 0.09%. CEQUA is an aqueous solution used to increase tear production in patients suffering from keratoconjunctivitis sicca (dry eye). CEQUA provides the highest FDA-approved concentration of cyclosporine A (CsA) and is based on nanomicellar technology. The innovative nanomicellar formulation used in CEQUA allows the CsA molecule to overcome the solubility challenges involved in the treatment of the dry eyes by penetrating the eye’s aqueous layer and preventing the release of the active lipophilic molecule before the actual penetration.
In May 2018, Teva Canada Ltd, a subsidiary of Teva Pharmaceutical Industries Ltd., had launched Teva-Cyclosporine ophthalmic emulsion, 0.05% w/v, a Health Canada approved twice-daily eye drop solution and the first generic version of Restasis (cyclosporine) in Canada. Cyclosporine ophthalmic emulsion is produced for the treatment of moderate to moderately severe aqueous deficient dry eye syndrome having ocular staining, reduction in tear production, and fluctuating visual symptoms.
A Full Report of Cyclosporine Drugs Market is Available at https://www.omrglobal.com/industry-reports/cyclosporine-drugs-market
Cyclosporine Drugs Market Segmentation
By Indication
• Rheumatoid Arthritis
• Psoriasis
• Transplant Rejection Prophylaxis
• Dry Eye
• Autoimmune Myasthenia Gravis
• Other
By Route of Administration
• Oral
• Parenteral
Cyclosporine Drugs market – Segment by Region
North America
• The US
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
Company Profiles
• AbbVie Inc.
• Allergan PLC
• Apotex, Inc.
• Mayne Pharma Group Ltd.
• Mckesson Medical Surgical Inc.
• Novartis AG
• Otsuka Pharmaceutical Co. Ltd.
• Regenerx Biopharmaceuticals, Inc.
• Santen Pharmaceuticals Co. Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/cyclosporine-drugs-market
For More Information, Visit https://www.omrglobal.com/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cyclosporine Drugs Market Share, Trends, Growth, Future Prospects, Forecast 2020 to 2026 here
News-ID: 2079928 • Views: …
More Releases from Orion Market Research
Bath Remodeling Market Will Exhibit an Impressive Expansion by 2024-2031 | AEC D …
Bath Remodeling Market is anticipated to grow at a significant CAGR of 5.0% during the forecast period. Increasing remodelling projects by rental property owners as they are heavily investing in their properties to enhance the value of owned property is a major factor fuelling to the growth of bath remodelling market. Property owners who are contributing towards bath improvement and remodelling activities are considering it as a wise investment which…
Baby Diaper Market is Size, Trends, Latest Insights, Analysis and Forecast 2024- …
The global baby diaper market is anticipated to grow at a considerable CAGR of 4.3% during the forecast period (2024-2031). Raw material shortages, supply chain disruptions and inflation are major restraints in the global baby diaper market. However, innovative and advanced product development is a major driver to the growth of the global baby diaper market during the forecast period. For instance, in June 2023, Charlie Banana launched new collection of reusable…
Aloe Vera Market Size Report Predicts Healthy Growth with Demand & Forecasts by …
The global aloe vera market is anticipated to grow at a considerable CAGR of 7.5% during the forecast period. The aloe vera plant has been used for thousands of years to heal a variety of conditions, most notably burns, wounds, skin irritations, and constipation. It contains numerous vitamins and minerals, enzymes, amino acids, natural sugars, and agents which are anti-inflammatory and anti-microbial in nature. With altering lifestyles and rising pollution…
Healthcare Distribution Market Size, Trends, Latest Insights, Analysis and Forec …
Global healthcare distribution market is anticipated to grow at a CAGR of 6.7% during the forecast period (2024-2031). Globally, a considerable increase in the burden of chronic diseases pressuring countries to adopt effective and efficient distribution of healthcare products. Commonly prevailing chronic diseases include heart attacks and strokes, cancer such as breast and colon, diabetes, epilepsy and seizures, obesity, and oral health issues.
To learn more about this report request…
More Releases for Cyclosporine
Cyclosporine Market Growth, Size, Share, Industry Report and Forecast 2021-2027
The global cyclosporine market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Cyclosporine works by suppressing the immune system's responses further preventing the immune system from attacking healthy tissues. The major factor attributed to the market growth includes the rising prevalence of target diseases that include inflammatory and autoimmune diseases, all over the globe. According to the World Psoriasis Day consortium, around 25 million people…
Global Cyclosporine drugs Market Size, Industry Trends, Share and Forecast - 202 …
The global cyclosporine drug market is estimated to grow at a CAGR of around 5% during the forecast period. A cyclosporine drug is a drug which used as medication during the organ transplant such as liver, kidney, heart. This prevents the new organ to function normally, where it works by weakening the immune system to assist the body to adapt the functionality of the body. Cyclosporine drug is an immunosuppressant…
Global Cyclosporine Market Growth 2018-2023
Market Research Report Store offers a latest published report on Cyclosporine Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Cyclosporine players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.To analyze the Cyclosporine with respect to individual growth trends, future…
Latest Report Cyclosporine Market 2023 : Size, Share, Forecast and Report Analys …
The global cyclosporine market has witnessed significant growth, owing to its widespread use in the medical industry as an oral medicine to treat inflammation in rheumatoid arthritis and psoriasis. In addition, it is used to prevent rejection of an organ transplant, which fuels its demand, thereby supplementing the market growth. However, health concerns associated with cyclosporine such as kidney problems, high blood pressure, gum diseases tremors, and increased body hair…
Cyclosporine Drugs Market Segmentation Detailed Study with Forecast to 2025
Cyclosporines are calcineurin inhibitors belonging to the immunosuppressant agent class of drugs. It is a metabolite extracted from the Tolypocladium fungus. Cyclosporine is a potent immunosuppressive agent that prolongs existence of allogeneic transplants in the lungs, small intestines, pancreas, heart, skin, liver, kidneys, and bone marrow. Cyclosporine suppresses certain cell-mediated immune reactions such as allograft rejection, encephalomyelitis, Freund’s adjuvant arthritis, graft diseases, experimental allergy, and delayed hypersensitivity for a variety…
Trends in Cyclosporine Drugs Market Detailed in New Research Report
Cyclosporines are calcineurin inhibitors belonging to the immunosuppressant agent class of drugs. It is a metabolite extracted from the Tolypocladium fungus. Cyclosporine is a potent immunosuppressive agent that prolongs existence of allogeneic transplants in the lungs, small intestines, pancreas, heart, skin, liver, kidneys, and bone marrow. Cyclosporine suppresses certain cell-mediated immune reactions such as allograft rejection, encephalomyelitis, Freund’s adjuvant arthritis, graft diseases, experimental allergy, and delayed hypersensitivity for a variety…
